Zusammenfassung
Die außergewöhnliche Fähigkeit humaner embryonaler Stammzellen (hES-Zellen), in alle somatischen Zell- und Gewebetypen differenzieren zu können, eröffnet vielversprechende Möglichkeiten für die Entwicklung neuer Ansätze zur Behandlung neurologischer Erkrankungen. Der vorliegende Beitrag soll anhand ausgewählter Beispiele einen Überblick über den derzeitigen Stand der Forschung auf diesem Gebiet geben. Es werden Methoden und Ergebnisse zur Gewinnung ausgewählter neuraler Zelltypen (dopaminerge Neurone, Retinazellen, Motorneurone, Oligodendrozyten) aus hES-Zellen vorgestellt und mögliche Probleme und Risiken der Nutzung dieser neuen Zellquelle im klinischen Kontext diskutiert.
Abstract
The remarkable capability of human embryonic stem cells (hES cells) to differentiate into all somatic cell types and tissues opens promising perspectives for the development of novel therapeutic approaches for neurological disorders. This article provides an overview on the current state of research in this field. We present strategies and results on the generation of selected neural subtypes (dopaminergic neurons, retinal progenitors, motoneurons, oligodendrocytes) and discuss problems and risks associated with a potential clinical application of this novel cell source.
Literatur
Zhang SC, Wernig M, Duncan ID, et al. (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129–1133
Reubinoff BE, Itsykson P, Turetsky T, et al. (2001) Neural progenitors from human embryonic stem cells. Nat Biotechnol 19:1134–1140
Perrier AL, Tabar V, Barberi T, et al. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101:12543–12548
Gerrard L, Rodgers L, Cui W (2005) Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 23:1234–1241
Benzing C, Segschneider M, Leinhaas A, et al. (2006) Neural conversion of human embryonic stem cell colonies in the presence of fibroblast growth factor-2. Neuroreport 17:1675–1681
Yan Y, Yang D, Zarnowska ED, et al. (2005) Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23:781–790
Li XJ, Du ZW, Zarnowska ED, et al. (2005) Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 23:215–221
Izrael M, Zhang P, Kaufman R, et al. (2007) Human oligodendrocytes derived from embryonic stem cells: Effect of Noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34:310–323
Li XJ, Hu BY, Jones SA, et al. (2008) Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells DOI: 10.1634/stemcells.2007–0620
Lee G, Kim H, Elkabetz Y, et al. (2007) Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 25:1468–1475
Lamba DA, Karl MO, Ware CB, Reh TA (2006) Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 103:12769–12774
Ladewig J, Koch P, Endl E, et al. (2008) Lineage selection of functional and cryopreservable human embryonic stem cell-derived neurons. Stem Cells doi:10.1634/stemcells. 2008–0007
Singh Roy N, Nakano T, Xuing L, et al. (2005) Enhancer-specified GFP-based FACS purification of human spinal motorneurons from embryonic stem cells. Exp Neurol 196:224–234
Pruszak J, Sonntag KC, Aung MH, et al. (2007) Markers and methods for cell sorting of human embryonic stem cell-derived cell populations. Stem Cells 25:2257–2268
Dunnett SB, Björklund A, Lindvall O (2001) Cell therapy in Parkinson’s disease – stop or go? Nat Rev Neurosci 2:365–369
Schulz TC, Noggle SA, Palmarini GM, et al. (2004) Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22:1218–1238
Roy NS, Cleren C, Singh SK, et al. (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259–1268
Ko JY, Park CH, Koh HC, et al. (2007) Human embryonic stem cell-derived neural precursors as a continuous, stable and on-demand source for human dopamine neurons. J Neurochem 103:1417–1429
Yang D, Zhang ZJ, Oldenburg M, et al. (2008) Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 26:55–63
Cho MS, Lee YE, Kim JY, et al. (2008) Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 4:3392–3397
Banin E, Obolensky A, Idelson M, et al. (2006) Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 24:246–257
Osakada F, Ikeda H, Mandai M, et al. (2008) Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 26:215–224
Lee H, Shamy GA, Elkabetz Y, et al. (2007) Directed differentiation and transplantation of human embryonic stem cell-derived motorneurons. Stem Cells 25:1931–1939
Brüstle O, Jones KN, Learish RD, et al. (1999) Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285:754–755
Nistor GI, Totoiu MO, Haque N, et al. (2005) Human embryonic stem cells differentiate into oligo-dendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49:385–396
Keirstead HS, Nistor G, Bernal G, et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4697–4705
Kang SM, Cho MS, Seo H, et al. (2007) Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 25:419–424
Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Draper JS, Smith K, Gokhale P, et al. (2004) Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53–54
Mitalipova MM, Rao RR, Hoyer DM, et al. (2005) Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23:19–20
Krystkowiak P, Gaura V, Labalette M, et al. (2007) Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington’s disease. PLoS ONE 2:e166
Taylor CJ, Bolton EM, Pocock S, et al. (2005) Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019–2025
Nakajima F, Tokunaga K, Nakatsuji N (2007) Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantations. Stem Cells 25:983–985
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Takahashi K, Tanabe K, Ohnuki M, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Yu J, Vodyanik MA, Smuga-Otto K, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920
Nakagawa M, Koyanagi M, Tanabe K, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101–106
Park IH, Zhao R, West JA, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141–146
Hanna J, Wernig M, Markoulaki S, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920–1923
Zwaka TP, Thomson JA (2003) Homologous recombination in human embryonic stem cells. Nat Biotechnol 21:319–321
Urbach A, Schuldiner M, Benvenisty N (2004) Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22:635–641
Abe Y, Kouyama K, Tomita T, et al. (2003) Analysis of neurons created from wild-type and Alzheimer’s mutation knock-in embryonic stem cells by a highly efficient differentiation protocol. J Neurosci 23:8513–8525
Verlinsky Y, Strelchenko N, Kukharenko V, et al. (2005) Human embryonic stem cell lines with genetic disorders. Reprod Biomed Online 10:105–110
Schmandt T, Goßrau G, Kischlat T, et al. (2006) Animal models for cell and gene therapy in myelin disease. Drug Discovery Today: Disease Models 3:349–358
Guan K, Nayernia K, Maier LS, et al. (2006) Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440:1199–1203
Seandel M, James D, Shmelkov SV, et al. (2007) Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 449:346–350
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nolden, L., Brüstle, O. Humane embryonale Stammzellen. Bundesgesundheitsbl. 51, 1026–1032 (2008). https://doi.org/10.1007/s00103-008-0631-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-008-0631-5
Schlüsselwörter
- Humane embryonale Stammzellen
- Neurale Differenzierung
- Zellersatztherapie
- Zellreprogrammierung
- Morbus Parkinson
- Morbus Huntington
- ALS
- Motorneuronerkrankung